中牧股份(600195.SH):擬與牧原股份設中牧牧原 以建南陽生產基地項目
格隆匯4月11日丨中牧股份(600195.SH)公佈,為積極落實公司“十四五”戰略規劃,加大自主研發產品的生產規模,鞏固公司在獸用化藥領域的市場地位,共建產業經營共同體。2022年4月11日,經公司第八屆董事會2022年第五次臨時會議審議通過了《關於中牧實業股份有限公司出資設立控股子公司及該子公司投資建設中牧牧原動物藥業有限公司南陽生產基地項目的議案》,同意公司及全資子公司南京藥業與牧原股份共同出資設立中牧牧原動物藥業有限公司,並簽署《中牧實業股份有限公司、牧原食品股份有限公司和中牧南京動物藥業有限公司之股東協議》,由中牧牧原投資建設中牧牧原動物藥業有限公司南陽生產基地項目,主要從事獸藥生產、獸藥經營、獸藥研發及技術諮詢服務。
中牧牧原註冊資金12000萬元,其中:中牧股份以現金方式出資5868萬元,佔註冊資本的48.9%;牧原股份以現金方式出資5760萬元,佔註冊資本的48%;南京藥業以現金方式出資372萬元,佔註冊資本的3.1%。南京藥業為中牧股份全資子公司,中牧牧原成立後,公司合計出資佔中牧牧原註冊資本的52%,中牧牧原為公司控股子公司。
中牧牧原動物藥業有限公司南陽生產基地項目建設投資47131.72萬元,項目建設資金由中牧牧原註冊資金解決,資金不足部分由中牧牧原以自籌資金解決。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.